Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind study of AG-013736 plus docetaxel versus docetaxel alone in metastatic breast cancer
2004-000971-33Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing AG-013736 + docetaxel with Placebo + docetaxel (2 arms). Started Feb 2005; status: completed.
02
Drugs
axitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-000971-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000971-33.